Cooperative group trials in pediatric oncology: The surgeon's role

被引：8
|
作者：
Shamberger, Robert C. [1 ,2 ]
机构：
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF PEDIATRIC SURGERY | 2013年 / 48卷 / 01期
关键词：
Children's Cancer Study Group; Intergroup Rhabdomyosarcoma Study; Pediatric Oncology Group; National Wilms Tumor Study Group; Cooperative group trials; Neuroblastoma; Wilms tumor; Rhabdomyosarcoma; Ewing's sarcoma; Osteosarcoma; NATIONAL WILMS-TUMOR; CHILDRENS CANCER GROUP; SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR; HIGH-RISK NEUROBLASTOMA; INTERGROUP RHABDOMYOSARCOMA; EWINGS-SARCOMA; RADIATION-THERAPY; PROGNOSTIC-SIGNIFICANCE; NEURO-BLASTOMA; STANDARD CHEMOTHERAPY;
D O I：
10.1016/j.jpedsurg.2012.10.068
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The early history of the pediatric cooperative group trials is reviewed, and the surgeons who played a critical role in their formation are discussed. The vital information provided from the tumor specimens submitted as part of the protocols is presented, as well as how this information advanced our management of infants and children treated on current protocols of the Children's Oncology Group. Finally, a survey of the surgeons currently active in the clinical trials defined the "critical lessons" learned from the sequence of protocols by the cooperative groups which have advanced our surgical treatment of patients today. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：1 / 13
页数：13
相关论文
共 50 条
  • [31] Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
    Fouladi, Maryam
    Park, Julie R.
    Stewart, Clinton F.
    Gilbertson, Richard J.
    Schaiquevich, Paula
    Sun, Junfeng
    Reid, Joel M.
    Ames, Matthew M.
    Speights, Roseanne
    Ingle, Ashish M.
    Zwiebel, James
    Blaney, Susan M.
    Adamson, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3623 - 3629
  • [32] A phase 2 trial of all-trans-retinoic acid in combination with interferon-α2A in children with recurrent neuroblastoma or Wilms tumor:: A pediatric oncology branch, NCI and children's oncology group study
    Adamson, Peter C.
    Matthay, Katherine K.
    O'Brien, Michelle
    Reaman, Gregory H.
    Sato, Judith K.
    Balis, Frank M.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (05) : 661 - 665
  • [33] Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study
    Kuttesch, John F., Jr.
    Krailo, Mark D.
    Madden, Timothy
    Johansen, Mary
    Bleyer, Archie
    PEDIATRIC BLOOD & CANCER, 2009, 53 (04) : 590 - 593
  • [34] Children's Oncology Group's 2013 blueprint for research: Epidemiology
    Spector, Logan G.
    Ross, Julie A.
    Olshan, Andrew F.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 1059 - 1062
  • [35] Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group
    Servaes, Sabah
    Khanna, Geetika
    Naranjo, Arlene
    Geller, James I.
    Ehrlich, Peter F.
    Gow, Kenneth W.
    Perlman, Elizabeth J.
    Dome, Jeffrey S.
    Gratias, Eric
    Mullen, Elizabeth A.
    PEDIATRIC RADIOLOGY, 2015, 45 (02) : 166 - 172
  • [36] Radiotherapy in pediatric medulloblastoma: Quality assessment of Pediatric Oncology Group Trial 9031
    Miralbell, R
    Fitzgerald, TJ
    Laurie, F
    Kessel, S
    Glicksman, A
    Friedman, HS
    Urie, M
    Kepner, JL
    Zhou, TN
    Chen, ZJ
    Barnes, P
    Kun, L
    Tarbell, NJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05): : 1325 - 1330
  • [37] Overview of bladder cancer trials in the Radiation Therapy Oncology Group
    Shipley, WU
    Kaufman, DS
    Tester, WJ
    Pilepich, MV
    Sandler, HM
    CANCER, 2003, 97 (08) : 2115 - 2119
  • [38] Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group
    Umaretiya, Puja J.
    Naranjo, Arlene
    Zhang, Fan F.
    Irwin, Meredith S.
    DuBois, Steven G.
    Bagatell, Rochelle
    Bona, Kira
    PEDIATRIC BLOOD & CANCER, 2024, 71 (07)
  • [39] Outcomes of the POG 9340/9341/9342 Trials for Children With High-Risk Neuroblastoma: A Report From the Children's Oncology Group
    Zage, Peter E.
    Kletzel, Morris
    Murray, Kevin
    Marcus, Robert
    Castleberry, Robert
    Zhang, Yang
    London, Wendy B.
    Kretschmar, Cynthia
    PEDIATRIC BLOOD & CANCER, 2008, 51 (06) : 747 - 753
  • [40] Experience of the Izmir pediatric oncology group on neuroblastoma:: IPOG-NBL-92 protocol
    Olgun, N
    Kansoy, SS
    Aksoylar, S
    Cetingul, N
    Vergin, C
    Oniz, H
    Sarialioglu, F
    Kantar, M
    Uysal, K
    Tuncyurek, M
    Kargi, A
    Aktas, S
    Bayol, Ü
    Karaca, I
    Arikan, A
    Balik, E
    Aktug, TJ
    Elmas, N
    Kovanlikaya, A
    Kinay, M
    Anacak, Y
    Degirmenci, B
    Burak, Z
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20 (03) : 211 - 218
12345